Clinical Trial Update: Role of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver Disease [Phase 2]

View source ↗

Summary

This update discusses a Phase 2 trial evaluating the roles of pioglitazone and berberine in treating nonalcoholic fatty liver disease, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease

Drugs mentioned

• Berberine (berberine)
• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Xin Gao | Conditions: Nonalcoholic Fatty Liver Disease | Phase 2 | Status: COMPLETED